356 related articles for article (PubMed ID: 28076849)
21. Serum metabolomics of laryngeal cancer based on liquid chromatography coupled with quadrupole time-of-flight mass spectrometry.
Zhang X; Hou H; Chen H; Liu Y; Wang A; Hu Q
Biomed Chromatogr; 2018 May; 32(5):e4181. PubMed ID: 29272549
[TBL] [Abstract][Full Text] [Related]
22. Metabolomics as a diagnostic tool for idiopathic non-cirrhotic portal hypertension.
Seijo S; Lozano JJ; Alonso C; Miquel R; Berzigotti A; Reverter E; Turon F; Martínez-Chantar ML; Castro A; Mato JM; Hernández-Gea V; Bosch J; García-Pagán JC
Liver Int; 2016 Jul; 36(7):1051-8. PubMed ID: 26394550
[TBL] [Abstract][Full Text] [Related]
23. Mass spectrometry-based quantitative metabolomics revealed a distinct lipid profile in breast cancer patients.
Qiu Y; Zhou B; Su M; Baxter S; Zheng X; Zhao X; Yen Y; Jia W
Int J Mol Sci; 2013 Apr; 14(4):8047-61. PubMed ID: 23584023
[TBL] [Abstract][Full Text] [Related]
24. Comparison of serum versus plasma collection in gas chromatography--mass spectrometry-based metabolomics.
Dettmer K; Almstetter MF; Appel IJ; Nürnberger N; Schlamberger G; Gronwald W; Meyer HH; Oefner PJ
Electrophoresis; 2010 Jul; 31(14):2365-73. PubMed ID: 20564267
[TBL] [Abstract][Full Text] [Related]
25. Metabolomic profile in pancreatic cancer patients: a consensus-based approach to identify highly discriminating metabolites.
Di Gangi IM; Mazza T; Fontana A; Copetti M; Fusilli C; Ippolito A; Mattivi F; Latiano A; Andriulli A; Vrhovsek U; Pazienza V
Oncotarget; 2016 Feb; 7(5):5815-29. PubMed ID: 26735340
[TBL] [Abstract][Full Text] [Related]
26. Investigations in the possibility of early detection of colorectal cancer by gas chromatography/triple-quadrupole mass spectrometry.
Nishiumi S; Kobayashi T; Kawana S; Unno Y; Sakai T; Okamoto K; Yamada Y; Sudo K; Yamaji T; Saito Y; Kanemitsu Y; Okita NT; Saito H; Tsugane S; Azuma T; Ojima N; Yoshida M
Oncotarget; 2017 Mar; 8(10):17115-17126. PubMed ID: 28179577
[TBL] [Abstract][Full Text] [Related]
27. The metabolomic detection of lung cancer biomarkers in sputum.
Cameron SJ; Lewis KE; Beckmann M; Allison GG; Ghosal R; Lewis PD; Mur LA
Lung Cancer; 2016 Apr; 94():88-95. PubMed ID: 26973212
[TBL] [Abstract][Full Text] [Related]
28. Alterations in arginine and energy metabolism, structural and signalling lipids in metastatic breast cancer in mice detected in plasma by targeted metabolomics and lipidomics.
Kus K; Kij A; Zakrzewska A; Jasztal A; Stojak M; Walczak M; Chlopicki S
Breast Cancer Res; 2018 Dec; 20(1):148. PubMed ID: 30514398
[TBL] [Abstract][Full Text] [Related]
29. Early detection of recurrent breast cancer using metabolite profiling.
Asiago VM; Alvarado LZ; Shanaiah N; Gowda GA; Owusu-Sarfo K; Ballas RA; Raftery D
Cancer Res; 2010 Nov; 70(21):8309-18. PubMed ID: 20959483
[TBL] [Abstract][Full Text] [Related]
30. NMR and LC/MS-based global metabolomics to identify serum biomarkers differentiating hepatocellular carcinoma from liver cirrhosis.
Liu Y; Hong Z; Tan G; Dong X; Yang G; Zhao L; Chen X; Zhu Z; Lou Z; Qian B; Zhang G; Chai Y
Int J Cancer; 2014 Aug; 135(3):658-68. PubMed ID: 24382646
[TBL] [Abstract][Full Text] [Related]
31. Using post-column infused internal standard assisted quantitative metabolomics for establishing prediction models for breast cancer detection.
Huang M; Li HY; Liao HW; Lin CH; Wang CY; Kuo WH; Kuo CH
Rapid Commun Mass Spectrom; 2020 Apr; 34 Suppl 1():e8581. PubMed ID: 31693758
[TBL] [Abstract][Full Text] [Related]
32. Metabolite patterns predicting sex and age in participants of the Karlsruhe Metabolomics and Nutrition (KarMeN) study.
Rist MJ; Roth A; Frommherz L; Weinert CH; Krüger R; Merz B; Bunzel D; Mack C; Egert B; Bub A; Görling B; Tzvetkova P; Luy B; Hoffmann I; Kulling SE; Watzl B
PLoS One; 2017; 12(8):e0183228. PubMed ID: 28813537
[TBL] [Abstract][Full Text] [Related]
33. Analysis of metabolites and metabolic pathways in breast cancer in a Korean prospective cohort: the Korean Cancer Prevention Study-II.
Yoo HJ; Kim M; Kim M; Kang M; Jung KJ; Hwang SM; Jee SH; Lee JH
Metabolomics; 2018 Jun; 14(6):85. PubMed ID: 30830383
[TBL] [Abstract][Full Text] [Related]
34. Metabolic signatures of esophageal cancer: NMR-based metabolomics and UHPLC-based focused metabolomics of blood serum.
Zhang X; Xu L; Shen J; Cao B; Cheng T; Zhao T; Liu X; Zhang H
Biochim Biophys Acta; 2013 Aug; 1832(8):1207-16. PubMed ID: 23524237
[TBL] [Abstract][Full Text] [Related]
35. A novel serum metabolome score for breast cancer diagnosis.
Rashed R; Darwish H; Omran M; Belal A; Zahran F
Br J Biomed Sci; 2020 Oct; 77(4):196-201. PubMed ID: 32546046
[TBL] [Abstract][Full Text] [Related]
36. 1H NMR Metabolomics Reveals Association of High Expression of Inositol 1, 4, 5 Trisphosphate Receptor and Metabolites in Breast Cancer Patients.
Singh A; Sharma RK; Chagtoo M; Agarwal G; George N; Sinha N; Godbole MM
PLoS One; 2017; 12(1):e0169330. PubMed ID: 28072864
[TBL] [Abstract][Full Text] [Related]
37. Breast cancer risk in relation to plasma metabolites among Hispanic and African American women.
Zhao H; Shen J; Moore SC; Ye Y; Wu X; Esteva FJ; Tripathy D; Chow WH
Breast Cancer Res Treat; 2019 Aug; 176(3):687-696. PubMed ID: 30771047
[TBL] [Abstract][Full Text] [Related]
38. Metabolome analysis for discovering biomarkers of gastroenterological cancer.
Suzuki M; Nishiumi S; Matsubara A; Azuma T; Yoshida M
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Sep; 966():59-69. PubMed ID: 24636738
[TBL] [Abstract][Full Text] [Related]
39. Serum Metabolomic Profiles for Breast Cancer Diagnosis, Grading and Staging by Gas Chromatography-Mass Spectrometry.
Hadi NI; Jamal Q; Iqbal A; Shaikh F; Somroo S; Musharraf SG
Sci Rep; 2017 May; 7(1):1715. PubMed ID: 28496143
[TBL] [Abstract][Full Text] [Related]
40. High resolution metabolomics to discriminate compounds in serum of male lung cancer patients in South Korea.
Pamungkas AD; Park C; Lee S; Jee SH; Park YH
Respir Res; 2016 Aug; 17(1):100. PubMed ID: 27506545
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
